Erlotinib Resistance is Altered after Gemcitabine Chemotherapy for Recurrent Non-Small-Cell Lung Cancer

Author: Wang Yongzheng  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.31, Iss.4, 2011-04, pp. : 279-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract